Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While BPC-157 is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects111, Thymosin Beta-4 promotes wound healing, angiogenesis, and tissue regeneration in preclinical models via effects on cytoskeleton dynamics, cell migration, and anti-apoptotic pathways25579.
While BPC-157 works as a synthetic 15-amino-acid fragment of a gastric cytoprotective protein that promotes angiogenesis and tissue protection primarily by modulating VEGFR2 signaling, Src/caveolin-1–dependent eNOS activation, and nitric oxide production111, Thymosin Beta-4 is an endogenous 43-amino-acid actin-sequestering peptide that maintains a pool of G-actin monomers and regulates actin polymerization, thereby influencing cell migration, proliferation, and differentiation25579.
BPC-157
Not assigned in the current dataset.
Thymosin Beta-4
TMSB4X
Both peptides fall into a similar broad context as Signal peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Musculoskeletal health and Dermatology and aesthetics contexts, while BPC-157 is more of a signal peptide and Thymosin Beta-4 is better described as a cytokine peptide. Both appear to work through Signaling modulator, which is one of the main reasons they can look related despite other differences. BPC-157 has a more synthetic analog origin, while Thymosin Beta-4 is closer to natural endogenous background with BPC-157 in Preclinical development and Thymosin Beta-4 in Clinical phase 2. Thymosin Beta-4 incorporates acetylation features that are not part of BPC-157, while their sequence patterns also diverge, with BPC-157 showing proline-rich features and Thymosin Beta-4 showing protein-mimetic sequence features.